Senior Vice President, Health Economics
jaime.caro@unitedbiosource.com
Jaime Caro, MDCM, FRCPC, FACP is an expert in advanced modeling techniques used to inform complex health care decisions. Dr. Caro trained at McGill University, where he practiced internal medicine and is now Adjunct Professor of Medicine, as well as Epidemiology and Biostatistics. He has established the graduate-level course in pharmacoeconomics at the University and also lends his teaching ability to other academic institutions, government organizations, and professional associations such as the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). After founding and leading the Caro Research Institute for more than a decade, he is now Senior Vice President for Health Economics at United BioSource Corporation.
His initial work in theoretical epidemiology led to applied research for the Health Technology Assessment Council of Quebec, a pioneer in the then nascent field. This early interest in the proper approach to evaluating health care interventions has resulted in efforts to help government organizations in countries as diverse as Germany and Colombia develop and implement their methodologies; and to appointments on the steering committees of various global initiatives to address specific diseases.
In addition to Dr. Caro’s work and publications on more than 100 disease models, he has continued active research on methods for modeling diseases and the application of epidemiologic concepts to economic studies. This has included the development of approaches for dealing with complex time dependencies and the transfer of modeling techniques from other fields to medicine—modifying discrete event simulation for use in economic and risk-benefit analyses and the modeling of adaptive clinical trials. More recently, he has focused on the development of a suitable metric to guide health care decisions.